Results from GenOMICC so far
The scientific and medical response to the COVID-19 pandemic has been truly inspiring. The aim of the GenOMICC study is to better understand and treat critically ill patients.
We do this by finding genetic differences between people who become critically ill and those who do not, to find out whether there are existing treatments available that might help this specific group. This work is very important.
The GenOMICC study have already found 5 genes that make people susceptible to life-threatening COVID-19, and in some cases lead us directly to therapeutic targets.
You can read our paper here!
This research demonstrates the potential of genomics in critical care medicine, but we still have many problems to solve. It will take a big effort, but our aim is to get to 100,000 critical illness genomes by the end of the decade!
If, as we all hope, Covid becomes a rare disease next year, we'll be 10% of the way there, but still with a long way to go. We really appreciate all your efforts and we're very keen to keep the momentum going.
With more research, there is a very high chance that we will find more, leading to new or repurposed drug treatments to improve care for these critically ill patients.